Preprint · CC-BY
via bioRxiv
NNMT promotes tubular senescence and fibrosis in chronic kidney disease
Chanvillard, L., Lantermans, H., Wall, C., Thevenet, J., Butter, L., Tauzin, L., Claessen, N., Christen, S., Karaz, S., Lassueur, S., Izzo, G., Sanchez Garcia, J. L., Metairon, S., Holzwarth, J., Ferro, V.
biorxiv · 2025
Abstract
Chronic kidney disease (CKD) is a major global health issue, projected to become the fifth leading cause of mortality by 2040. Renal tubular cell senescence(definition) is a key driver of kidney fibrosis, the final manifestation of CKD. However, current treatment strategies, do not target senescent cells, as the underlying mechanisms driving this dysfunctional phenotype remain poorly described. Here, we identify nicotinamide-N-methyltransferase (NNMT), as a critical mediator of tubular senescence and fibrosis in CKD. Using human RNAseq profiles of CKD, we show that NNMT expression in the renal tubulointerstitium is strongly associated with CKD pathology and transcriptional signatures of cellular senescence. In human diabetic kidney disease biopsies, NNMT levels correlate with the senescence marker p21, kidney function decline, and fibrosis. Spatial transcriptomics further highlights that NNMT-positive tubules are senescent, fibrotic, and surrounded by a pro-inflammatory microenvironment. Preclinical models of early-stage CKD, show upregulation of NNMT and association with senescence. Overexpression of NNMT in TGF-{beta}-stimulated tubular epithelial cells promotes senescence and partial epithelial-to-mesenchymal transition (EMT), while inhibition of NNMT in kidney cells and organoids is protective. Altogether, we identify NNMT as a novel therapeutic target in the early stages of CKD with the potential to reduce tubular senescence, fibrosis and significantly slow disease progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2025.01.06.631437
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
L., C., H., L., C., W., J., T., L., B., L., T., N., C., S., C., S., K., S., L., G., I., L., S.G.J., S., M., J., H., V., F., S., M., E., V.B., M., V.B., A., H., & D., V.R. (2025). NNMT promotes tubular senescence and fibrosis in chronic kidney disease. <em>biorxiv</em>. https://doi.org/10.1101/2025.01.06.631437
Vancouver
L. C, H. L, C. W, J. T, L. B, L. T, et al. NNMT promotes tubular senescence and fibrosis in chronic kidney disease. biorxiv. 2025. doi:10.1101/2025.01.06.631437.
BibTeX
@unpublished{chanvillard2025NNMTpr,
title = {NNMT promotes tubular senescence and fibrosis in chronic kidney disease},
author = {Chanvillard, L. and Lantermans, H. and Wall, C. and Thevenet, J. and Butter, L. and Tauzin, L. and Claessen, N. and Christen, S. and Karaz, S. and Lassueur, S. and Izzo, G. and Sanchez Garcia, J. L. and Metairon, S. and Holzwarth, J. and Ferro, V. and Moco, S. and van Bommel, E. and van Baar, M. and Hesp, A. and van Raalte, D. and Roelofs, J. and Sanders, M. and Feige, J. and Sorrentino, V. and Tammaro, A.},
journal = {biorxiv},
year = {2025},
doi = {10.1101/2025.01.06.631437},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JCI Insight 2023
Open access · CC-BY
Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity
Biochemical and biophysical research communications 2026
Citation only
Renal tubular epithelial-derived Angptl4 promotes renal fibrosis by inducing tubular cell senescence.
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease
Frontiers in Endocrinology 2023
Open access · CC-BY
Cellular senescence of renal tubular epithelial cells in renal fibrosis
Frontiers in Pharmacology 2020
Open access · CC-BY
High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis
Frontiers in Pharmacology 2020
Open access · CC-BY